GlassScriptPhysician profile
Michael S Roberts
NPI 1932159357
$12,813.59
in general payments reported to CMS, 2019-2025
43 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,788 · 2020: $2,239 · 2021: $123 · 2022: $6,167 · 2023: $1,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,406 · Food and Beverage: $90.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,406.25 |
| Food and Beverage | $90.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $7,545.91 | 2019-2023 | |
| Adaptive Biotechnologies Corporation | $1,000.00 | 2020 | |
| Genzyme Corporation | $483.96 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $398.42 | 2019-2020 | |
| Pfizer INC. | $372.73 | 2019-2021 | |
| Seagen INC. | $295.93 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $286.39 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $279.30 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $238.03 | 2019-2020 | |
| Eisai INC. | $204.50 | 2019-2020 | |
| Amgen INC. | $174.58 | 2019-2020 | |
| Genentech USA, INC. | $149.58 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.02 | 2019-2020 | |
| Celgene Corporation | $109.20 | 2019-2021 | |
| Emd Serono, INC. | $103.99 | 2019-2021 |
Show all 42 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.